CanniMed Therapeutics Inc.

(TSX:CMED) (OTC:CMMDF) (FRA:0GB)

Company Description:

CanniMed is a Canadian-based, international plant biopharmaceutical company and leader in the Canadian medical cannabis industry, with 15 years’ of pharmaceutical cannabis cultivation experience, state-of-the-art, a GMP-compliant production process, including 281 points of quality control and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.

The Company also has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

Latest News & Stories on CanniMed Therapeutics Inc. (TSX:CMED) (OTC:CMMDF) (FRA:0GB)

Aurora Completes Acquisition of CanniMed Therapeutics

May 2, 2018

Aurora Gains Exclusive License to Sub-Lingual Wafer Technology

April 16, 2018

Aurora's Andrċ Jérôme Appointed Interim CEO of CanniMed

April 2, 2018

CanniMed Therapeutics Inc. Announces First Quarter Results

March 19, 2018

CanniMed Therapeutics to Report Quarterly Financials Next Week

March 16, 2018

Aurora Cannabis Succeeds in Bid for CanniMed - Takes Up Shares

March 9, 2018

Aurora Receives Final Regulatory Approval for CanniMed Acquisition

February 28, 2018

Aurora Cannabis and CanniMed Therapeutics File Offer Documents

February 6, 2018

Aurora Cannabis Becomes the World’s Largest Marijuana Producer

January 25, 2018

Newstrike to Receive $9.5 Million Break Fee Following Termination of Agreement

January 24, 2018

Aurora Cannabis Makes New Offer to Acquire CanniMed

January 24, 2018

Newstrike Resources Provides Update on CanniMed Transaction

January 23, 2018

CanniMed Therapeutics Announces Continuation of Discussions with Aurora

January 22, 2018

CanniMed Launches Topical Cream for Pain and Inflamation

January 17, 2018

CanniMed Announces German Distribution Agreement with Fagron

January 10, 2018

Canada Blazes Into 2018 With Corporate Cannabis Deals

January 8, 2018

Securities Regulators Rule In Favor of Aurora

December 27, 2017

31 Companies Currently Held by the New Cannabis-Focused ETF

December 26, 2017

Aurora Rebuts CanniMed's Call for Government Intervention

December 11, 2017

Canabo Announces Launch of its Canada-Wide VIP Program

December 7, 2017

TSX Defers Consideration of CanniMed Therapeutics Shareholder Rights Plan

December 5, 2017

Aurora Responds to CanniMed's Adoption of Poison Pill Tactic

December 1, 2017

CanniMed Receives License from Health Canada to Produce MMJ Capsules

October 16, 2017

CanniMed Therapeutics Inc. Adds 2 New Vice Presidents

September 14, 2017

S&P Indices Adds Cannabis Company to the S&P/TSX SmallCap Index

September 11, 2017

Cronos Group's Peace Naturals Begins Exports to the Cayman Islands

August 29, 2017

CanniMed Therapeutics Expands International Supply Partnerships to Africa

August 24, 2017

Insider Selling by CanniMed Therapeutics' Chief Research Officer

August 2, 2017

CanniMed Therapeutics Q2 2017 Financial Results Breakdown

June 12, 2017

Marijuana Stocks On The Toronto Stock Exchange

May 25, 2017

First MMJ Shipment Arrives in Australia... One Problem

May 3, 2017

CanniMed Fulfills Cannabis Oil Export to Cayman Islands

May 3, 2017

CanniMed Therapeutics Completes First Cannabis Oil Export To Australia

May 2, 2017

CanniMed Therapeutics Commences Cannabis Oils Facility Expansion

April 19, 2017

The North American Medical Marijuana Basket

April 18, 2017

Index in Focus - North American Medical Marijuana Index

March 28, 2017

CanniMed Therapeutics Inc. Receives Two Export Permits from Health Canada

March 22, 2017

CanniMed Therapeutics Corrects Q1 Avg. Selling Prices

March 17, 2017

CTT Pharma and CanniMed Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film Wafer

February 17, 2017

CanniMed Therapeutics Inc. Provides Update on Patient Growth Rates, Sales Volume and Product Supply

February 3, 2017

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.